FIG 3.
Simulated versus observed proportion of subjects receiving tafenoquine for determining relapse-free status at 6 months by country (logistic regression analysis). Left panel, Brazil/Peru; right panel, Thailand.
Simulated versus observed proportion of subjects receiving tafenoquine for determining relapse-free status at 6 months by country (logistic regression analysis). Left panel, Brazil/Peru; right panel, Thailand.